These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. A 13-year-old girl with proximal weakness and hypertrophic cardiomyopathy with Danon disease. Kim H; Cho A; Lim BC; Kim MJ; Kim KJ; Nishino I; Hwang YS; Chae JH Muscle Nerve; 2010 Jun; 41(6):879-82. PubMed ID: 20513107 [TBL] [Abstract][Full Text] [Related]
5. Extension of the clinical spectrum of Danon disease. van der Kooi AJ; van Langen IM; Aronica E; van Doorn PA; Wokke JH; Brusse E; Langerhorst CT; Bergin P; Dekker LR; dit Deprez RH; de Visser M Neurology; 2008 Apr; 70(16):1358-9. PubMed ID: 18413590 [No Abstract] [Full Text] [Related]
6. Danon disease: a focus on processing of the novel LAMP2 mutation and comments on the beneficial use of peripheral white blood cells in the diagnosis of LAMP2 deficiency. Majer F; Vlaskova H; Krol L; Kalina T; Kubanek M; Stolnaya L; Dvorakova L; Elleder M; Sikora J Gene; 2012 May; 498(2):183-95. PubMed ID: 22365987 [TBL] [Abstract][Full Text] [Related]
8. Danon disease caused by two novel mutations of the LAMP2 gene: implications for two ends of the clinical spectrum. Hong D; Shi Z; Wang Z; Yuan Y Clin Neuropathol; 2012; 31(4):224-31. PubMed ID: 22541782 [TBL] [Abstract][Full Text] [Related]
9. Novel LAMP-2 mutation in a family with Danon disease presenting with hypertrophic cardiomyopathy. Dougu N; Joho S; Shan L; Shida T; Matsuki A; Uese K; Hirono K; Ichida F; Tanaka K; Nishino I; Inoue H Circ J; 2009 Feb; 73(2):376-80. PubMed ID: 19057086 [TBL] [Abstract][Full Text] [Related]
10. Danon disease as a cause of autophagic vacuolar myopathy. Yang Z; Vatta M Congenit Heart Dis; 2007; 2(6):404-9. PubMed ID: 18377432 [TBL] [Abstract][Full Text] [Related]
11. Novel Lamp-2 gene mutation and successful treatment with heart transplantation in a large family with Danon disease. Echaniz-Laguna A; Mohr M; Epailly E; Nishino I; Charron P; Richard P; Guiraud-Chaumeil C; Tranchant C Muscle Nerve; 2006 Mar; 33(3):393-7. PubMed ID: 16372318 [TBL] [Abstract][Full Text] [Related]
12. Identification of LAMP2 Mutations in Early-Onset Danon Disease With Hypertrophic Cardiomyopathy by Targeted Next-Generation Sequencing. Fu L; Luo S; Cai S; Hong W; Guo Y; Wu J; Liu T; Zhao C; Li F; Huang H; Huang M; Wang J Am J Cardiol; 2016 Sep; 118(6):888-894. PubMed ID: 27460667 [TBL] [Abstract][Full Text] [Related]
13. Danon disease: further clinical and molecular heterogeneity. Sabourdy F; Michelakakis H; Anastasakis A; Garcia V; Mavridou I; Nieto M; Pons MC; Skiadas C; Moraitou M; Manta P; Elleder M; Levade T Muscle Nerve; 2009 Jun; 39(6):837-44. PubMed ID: 19373884 [TBL] [Abstract][Full Text] [Related]
14. Electron microscopic findings in skin biopsies from patients with Danon disease. Alroy J; Pfannl R; Slavov D; Taylor MR Ultrastruct Pathol; 2010 Dec; 34(6):333-6. PubMed ID: 21070164 [TBL] [Abstract][Full Text] [Related]
15. Advantages of a subcutaneous implantable cardioverter-defibrillator in LAMP2 hypertrophic cardiomyopathy. Zaki A; Zaidi A; Newman WG; Garratt CJ J Cardiovasc Electrophysiol; 2013 Sep; 24(9):1051-3. PubMed ID: 23577876 [TBL] [Abstract][Full Text] [Related]